After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for Nkarta Inc (NKTX) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.05, or 2.17%, to $2.35. The Nkarta Inc has recorded 43,932 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Lupus Therapeutics Announces Partnership to Support the Evaluation of Natural Killer (NK) Cell Therapy in Lupus Nephritis.
NKTX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $2.30 and fluctuated between $2.3350 as its day high and $1.9600 as its day low. The current market capitalization of Nkarta Inc is $112.84M. A total of 1.91 million shares were traded on the day, compared to an average of 2.44M shares.
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, NKTX has seen 0 BUY and 1 SELL insider trades, representing the acquisition of 0 and the disposition of 1,331 shares. Over the last 12 months, there were 6 BUYs and 13 SELLs from insiders. Insiders purchased 235,500 shares during that period but sold 13,058.
In the most recent transaction, Shook David sold 1,331 shares of NKTX for 1.83 per share on Aug 21. After the transaction, the Chief Medical Officer now owns 60,532 company shares. In a previous transaction on Jun 20, HASTINGS PAUL J sold 1,704 shares at 4.85 per share. NKTX shares that Chief Executive Officer owns now total 313,402.
Among the insiders who sold shares, Hager Alicia J. disposed of 701 shares on Jun 20 at a per-share price of $4.85. This resulted in the Chief Legal Officer holding 56,496 shares of NKTX after the transaction. In another insider transaction, Mahmood Nadir sold 526 shares at $4.85 per share on Jun 20. Company shares held by the insider now total 85,776.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for NKTX in the last 3 months, the mean price target is $15.38 with high estimates of $25.00 and low estimates of $10.00. In terms of 52-week highs and lows, NKTX has a high of $12.68 and a low of $1.28.
As of this writing, NKTX has an earnings estimate of -$0.67 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of -$0.4 per share and a lower estimate of -$0.8. The company reported an EPS of -$0.63 in the last quarter, which was 10.00% higher than expectations of -$0.7.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. NKTX’s latest balance sheet shows that the firm has $240.19M in Cash & Short Term Investments as of fiscal 2021. There were $12.46M in debt and $10.48M in liabilities at the time. Its Book Value Per Share was $6.48, while its Total Shareholder’s Equity was $250.97M.
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NKTX is Buy with a score of 4.89.